Industry Newsroom

IDG Leads USD80m Series B for Chinese Biotech Firm PTM Biolabs

IDG Capital led a USD80m Series B for China-based biotech firm PTM Biolabs, with participation from Fortune Capital, Highlight Capital, and SDIC Venture Capital. Read more